Identification of PI3K regulatory subunit p55γ as a novel inhibitor of vascular smooth muscle cell proliferation and neointimal formation

Cardiovasc Res. 2015 Jan 1;105(1):75-85. doi: 10.1093/cvr/cvu235. Epub 2014 Nov 10.

Abstract

Aims: Phosphatidylinositol 3 kinases (PI3Ks) play a pivotal role in vascular physiology and pathophysiology. We aimed to investigate the role of p55γ, a regulatory subunit of PI3Ks, in vascular smooth muscle cell (VSMC) proliferation and neointimal formation.

Methods and results: We identified p55γ as an important factor that suppresses VSMC proliferation and injury-evoked neointimal formation. Western blot and mRNA analyses showed that p55γ expression declined in balloon-injured rat carotid arteries and in response to PDGF-BB and serum treatment in cultured VSMCs. Overexpression of p55γ inhibited, whereas short hairpin RNA knockdown of p55γ promoted PDGF-BB- and serum-induced VSMC proliferation. Importantly, in vivo adenoviral gene transfer of p55γ into carotid arteries attenuated, while knockdown of p55γ enhanced balloon injury-induced neointimal formation. Furthermore, p55γ sequentially up-regulated p53 and p21, resulting in cell-cycle arrest in S phase; small-interfering RNA knockdown of either p53 or p21 blocked p55γ-induced VSMC growth arrest. Mechanistically, p55γ interacted with and stabilized p53 protein by blocking mouse double minute 2 homologue-mediated p53 ubiquitination and degradation, subsequently activating its target gene p21. Concurrently, p55γ up-regulated Bcl-xl expression, resulting in non-apoptotic growth arrest effect.

Conclusion: These findings mark p55γ as a novel upstream regulator of the p53-p21 signalling pathway that negatively regulates VSMC proliferation, suggesting that malfunction of p55γ may trigger vascular proliferative disorders.

Keywords: Neointimal formation; Restenosis; Vascular smooth muscle cell proliferation; p55γ.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Carotid Artery Injuries / enzymology
  • Carotid Artery Injuries / pathology
  • Cell Cycle Checkpoints
  • Cell Proliferation
  • Cells, Cultured
  • Class Ia Phosphatidylinositol 3-Kinase / genetics
  • Class Ia Phosphatidylinositol 3-Kinase / metabolism*
  • Cyclin-Dependent Kinase Inhibitor p21 / metabolism
  • Gene Knockdown Techniques
  • Humans
  • Male
  • Muscle, Smooth, Vascular / enzymology*
  • Muscle, Smooth, Vascular / pathology*
  • Neointima / enzymology*
  • Neointima / pathology
  • Neointima / prevention & control*
  • Phosphatidylinositol 3-Kinases / genetics
  • Phosphatidylinositol 3-Kinases / metabolism
  • Phosphoinositide-3 Kinase Inhibitors
  • Proto-Oncogene Proteins c-mdm2 / metabolism
  • RNA, Messenger / genetics
  • RNA, Messenger / metabolism
  • Rats
  • Rats, Sprague-Dawley
  • Signal Transduction
  • Tumor Suppressor Protein p53 / metabolism
  • Up-Regulation
  • bcl-X Protein / antagonists & inhibitors
  • bcl-X Protein / genetics
  • bcl-X Protein / metabolism

Substances

  • Bcl2l1 protein, rat
  • Cyclin-Dependent Kinase Inhibitor p21
  • Phosphoinositide-3 Kinase Inhibitors
  • RNA, Messenger
  • Tumor Suppressor Protein p53
  • bcl-X Protein
  • Mdm2 protein, rat
  • Proto-Oncogene Proteins c-mdm2
  • Class Ia Phosphatidylinositol 3-Kinase
  • PIK3R3 protein, human